Company which developed Aquablation Therapy for Benign Prostatic Hyperplasia (BPH) Treatment.
Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), the company’s first product, the AQUABEAM Robotic System delivering Aquablation therapy, is the world’s first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat BPH. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.
Visit website: https://www.procept-biorobotics.com/
PROCEPT BioRobotics News
8 Types of Robotic Surgery Being Used Today
Nanalyze - 20-Jul-2018
Brief description of available robotic surgery procedures and their corresponding equipmentRead more...